GeneDx Holdings Corp.
For the period ended Jun 30, 2025. Filed Jul 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 29, 2025
WGS$65.72+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into this Quarterly Report.
| No. | Description of Exhibit | Filed Herewith |
| 3.1# | Third Amended and Restated Certificate of Incorporation, as amended. | X |
| 10.1* | Non-Employee Director Compensation Policy, effective April 10, 2025. | X |
| 10.2 | Joinder Agreement, dated July 2, 2025 by Fabric Genomics, Inc. in favor of Perceptive Credit Holdings IV, LP. | X |
| 10.3 | Guarantee Assumption Agreement, dated July 2, 2025, by Fabric Genomics, Inc. | X |
| 31.1 | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X |
| 31.2 | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X |
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X |
| 99*** | Policy Relating to Recovery of Erroneously Awarded Compensation. | X |
| 101.INS | Inline XBRL Instance Document. | X |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | X |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | X |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | X |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. | X |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | X |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibit 101). | X |
| # | The Company is refiling its Third Amended and Restated Certificate of Incorporation, together with the Certificates of Amendments thereto, in one consolidated exhibit. | |
| * | Management Contract or Compensatory Plan | |
| ** | Furnished | |
| *** | This exhibit was previously listed as Exhibit 97.1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 incorporated such exhibit by reference. However, the hyperlink to this exhibit was inadvertently omitted when the Annual Report on Form 10-K for the year ended December 31, 2023 was filed. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.